Delivery Order SPE2DE24D0013-SPE2D625F1KTN
- Not listed
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain function, awarded a $20.4K firm fixed-price delivery order to Cepheid Inc. on September 18, 2025, with a completion date of September 25, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic solutions for COVID-19, influenza, and respiratory syncytial virus (RSV) testing, with performance to be executed at Cepheid's facility in Sunnyvale, California. This award carries no set-aside...
- The U.S. Defense Logistics Agency, through the Medical Supply Chain division, awarded a $4,080 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, issued on June 18, 2025, with an ultimate completion date of June 26, 2025, is designated as XPCOV2/FLU/RSV-10 and carries no set-aside designation. The delivery order addresses federal requirements for COVID-19, influenza, and respiratory syncytial virus...
- The U.S. Defense Logistics Agency awarded a $29,478.60 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on August 6, 2025, with an ultimate completion date of August 13, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The contract carries no set-aside designation and represents a relatively modest...
- The U.S. Defense Department's Medical Supply Chain awarded a $3,400 firm fixed-price delivery order to Cepheid Inc. on May 19, 2025, with completion targeted for May 27, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV)—infectious disease testing capabilities aligned with federal pandemic preparedness and ongoing surveillance needs. The order carries no set-aside designation and...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain program, awarded a $8,995.14 firm fixed-price delivery order to Cepheid Inc. on May 6, 2025, for molecular diagnostic solutions with an ultimate completion date of May 13, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, references testing capabilities for COVID-19, influenza, and respiratory syncytial virus (RSV)—aligning with Cepheid's core diagnostic product offerings. The contract carries no set-aside...
- The U.S. Defense Department's Medical Supply Chain awarded a $204,000 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on September 15, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by September 22, 2025, and carries no set-aside designation. This award represents a continuation of the department's partnership with Cepheid to procure diagnostic testing solutions, specifically for...
- The Defense Logistics Agency's Medical Supply Chain division awarded an $8,160 firm fixed-price delivery order to Cepheid Inc. on August 13, 2025, with an ultimate completion date of August 20, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic testing solutions, specifically reagents and assays for COVID-19, influenza, and respiratory syncytial virus detection. The contract carries no set-aside designation and is performed at Cepheid's facility in...
- The U.S. Department of Defense, through its Medical Supply Chain division, awarded a $20,400 firm fixed-price delivery order to Cepheid Inc. on July 10, 2025, with an ultimate completion date of July 17, 2025. The contract, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). Cepheid, a Sunnyvale, California-based manufacturer specializing in advanced diagnostic systems, will perform the work at its...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $27,650.40 firm fixed-price delivery order to Cepheid Inc. on September 18, 2025, with completion targeted for September 25, 2025. The delivery order, identified as XPRSMVP-10 (Contract Number 4569505244), is being performed at Cepheid's headquarters in Sunnyvale, California. This award carries no set-aside designation and represents a discrete procurement under the company's broader federal contracting relationship with...
- The U.S. Defense Department's Medical Supply Chain awarded a $8,160 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostic solutions manufacturer based in Sunnyvale, California, on September 2, 2025. This delivery order, designated 4569302270 for XPCOV2/FLU/RSV-10 testing solutions, is scheduled for completion by September 9, 2025, with work performed at the contractor's Sunnyvale facility. The award carries no small business set-aside designation and represents part of...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F1KTNDelivery Order
The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded a $20,400 firm fixed-price delivery order to Cepheid Inc. on August 20, 2025, with completion scheduled for August 27, 2025. This delivery order, designated 4569159076 XPCOV2/FLU/RSV-10, utilizes no set-aside designation and represents procurement of molecular diagnostic solutions from the Sunnyvale, California-based manufacturer. The award falls under Cepheid's larger Indefinite Delivery Vehicle relationships with federal healthcare systems, which enable continuous procurement of diagnostic testing capabilities. Cepheid specializes in GeneXpert diagnostic systems and associated molecular reagent test kits for detecting infectious diseases including COVID-19, influenza, and respiratory syncytial virus—conditions directly referenced in this delivery order's designation. The company maintains extensive federal contracting experience across the Department of Veterans Affairs, Indian Health Service, and Defense Health Agency, with existing IDV contracts valued in the tens of millions of dollars. This particular delivery order represents continued procurement of diagnostic testing supplies and equipment maintenance services to support defense healthcare operations, consistent with Cepheid's established role as a primary supplier of molecular diagnostic technologies to federal medical systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.4k | 8/20/25 |